 |
||||
| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
|
||||
| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Epidemiology and Outcomes |
* VA Pittsburgh Healthcare System and Renal-Electrolyte Division, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania; Collaborative Health Studies Coordinating Center, University of Washington, Seattle, Washington; Division of Nephrology, Department of Medicine, Tufts-New England Medical Center, Boston, Massachusetts; General Internal Medicine Section, Veterans Affairs Medical Center and Departments of Medicine, Epidemiology, and Biostatistics, University of California, San Francisco, San Francisco, California; || Departments of Medicine and Epidemiology, Johns Hopkins University, Baltimore, Maryland; ¶ Department of Pathology, College of Medicine, University of Vermont, Burlington, Vermont; # Amgen, Thousand Oaks, California; ** Department of Statistics, University of California, Irvine, Irvine, California; Section of Nephrology, Wake Forest University School of Medicine, Winston-Salem, North Carolina; Departments of Medicine and Public Health Sciences, University of California, Davis Medical Center, Sacramento, CA; Department of Medicine, Epidemiology and Health Services, University of Washington, Seattle, Washington; |||| Department of Epidemiology, University of Pittsburgh Graduate School of Public Health and Division of Geriatric Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
Address correspondence to: Dr. Linda Fried, VA Pittsburgh Healthcare System, University Drive C, Mailstop 111F-U, Pittsburgh, PA 15240. Phone: 412-688-6181; Fax: 412-688-6908; E-mail: linda.fried{at}med.va.gov
Received for publication April 11, 2005. Accepted for publication September 13, 2005.
Chronic kidney disease is associated with a higher risk for cardiovascular mortality, as well as all-cause mortality. Whether chronic kidney disease is a predictor of noncardiovascular mortality is less clear. To further explore the latter, the association of kidney function with total noncardiovascular mortality and cause-specific mortality was assessed in the Cardiovascular Health Study, a community-based cohort of older individuals. Kidney disease was assessed using cystatin C and estimated GFR in 4637 participants in 1992 to 1993. Participants were followed until June 30, 2001. Deaths were adjudicated as cardiovascular or noncardiovascular disease by committee, and an underlying cause of death was assigned. The associations of kidney function with total noncardiovascular mortality and cause-specific mortality were analyzed by proportional hazards regression. Noncardiovascular mortality rates increased with higher cystatin C quartiles (16.8, 17.1, 21.6, and 50.0 per 1000 person-years). The association of cystatin C with noncardiovascular mortality persisted after adjustment for demographic factors; the presence of diabetes, C-reactive protein, hemoglobin, and prevalent cardiovascular disease; and measures of atherosclerosis (hazard ratio 1.69; 95% confidence interval 1.33 to 2.15, for the fourth quartile versus the first quartile). Results for estimated GFR were similar. The risk for noncardiac deaths attributed to pulmonary disease, infection, cancer, and other causes was similarly associated with cystatin C levels. Kidney function predicts noncardiovascular mortality from multiple causes in the elderly. Further research is needed to understand the mechanisms and evaluate interventions to reduce the high mortality rate in chronic kidney disease.
This article has been cited by other articles:
 |
|
 |
|
  M. T. James, K. B. Laupland, M. Tonelli, B. J. Manns, B. F. Culleton, B. R. Hemmelgarn, and for the Alberta Kidney Disease Network Risk of Bloodstream Infection in Patients With Chronic Kidney Disease Not Treated With Dialysis Arch Intern Med, November 24, 2008; 168(21): 2333 - 2339. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. S. Fox and P. Muntner Trends in Diabetes, High Cholesterol, and Hypertension in Chronic Kidney Disease Among U.S. Adults: 1988-1994 to 1999-2004 Diabetes Care, July 1, 2008; 31(7): 1337 - 1342. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. B. Newman, R. M. Boudreau, B. L. Naydeck, L. F. Fried, and T. B. Harris A Physiologic Index of Comorbidity: Relationship to Mortality and Disability J. Gerontol. A Biol. Sci. Med. Sci., June 1, 2008; 63(6): 603 - 609. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Jorgensen, I. Heuch, T. Jenssen, and B. K. Jacobsen Association of Albuminuria and Cancer Incidence J. Am. Soc. Nephrol., May 1, 2008; 19(5): 992 - 998. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Yang, W. Y. So, P. C. Y. Tong, R. C. W. Ma, A. P. S. Kong, C. W. K. Lam, C. S. Ho, C. S. Cockram, G. T. C. Ko, C.-C. Chow, et al. Development and Validation of an All-Cause Mortality Risk Score in Type 2 Diabetes: The Hong Kong Diabetes Registry Arch Intern Med, March 10, 2008; 168(5): 451 - 457. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Khatri, C. B. Wright, T. L. Nickolas, M. Yoshita, M. C. Paik, G. Kranwinkel, R. L. Sacco, and C. DeCarli Chronic Kidney Disease Is Associated With White Matter Hyperintensity Volume: The Northern Manhattan Study (NOMAS) Stroke, December 1, 2007; 38(12): 3121 - 3126. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. E. Weiner, H. Tighiouart, E. F. Elsayed, J. L. Griffith, D. N. Salem, A. S. Levey, and M. J. Sarnak The Framingham Predictive Instrument in Chronic Kidney Disease J. Am. Coll. Cardiol., July 17, 2007; 50(3): 217 - 224. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Foster, S.-J. Hwang, M. G. Larson, N. I. Parikh, J. B. Meigs, R. S. Vasan, T. J. Wang, D. Levy, and C. S. Fox Cross-Classification of Microalbuminuria and Reduced Glomerular Filtration Rate: Associations Between Cardiovascular Disease Risk Factors and Clinical Outcomes Arch Intern Med, July 9, 2007; 167(13): 1386 - 1392. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. L. Schiffrin, M. L. Lipman, and J. F.E. Mann Chronic Kidney Disease: Effects on the Cardiovascular System Circulation, July 3, 2007; 116(1): 85 - 97. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Maaravi, M. Bursztyn, R. Hammerman-Rozenberg, and J. Stessman Glomerular filtration rate estimation and mortality in an elderly population QJM, July 1, 2007; 100(7): 441 - 449. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. H. Ix, M. G. Shlipak, G. M. Chertow, and M. A. Whooley Association of Cystatin C With Mortality, Cardiovascular Events, and Incident Heart Failure Among Persons With Coronary Heart Disease: Data From the Heart and Soul Study Circulation, January 16, 2007; 115(2): 173 - 179. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. G. Shlipak, R. Katz, M. J. Sarnak, L. F. Fried, A. B. Newman, C. Stehman-Breen, S. L. Seliger, B. Kestenbaum, B. Psaty, R. P. Tracy, et al. Cystatin C and Prognosis for Cardiovascular and Kidney Outcomes in Elderly Persons without Chronic Kidney Disease Ann Intern Med, August 15, 2006; 145(4): 237 - 246. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Bibbins-Domingo, G. M. Chertow, L. F. Fried, M. C. Odden, A. B. Newman, S. B. Kritchevsky, T. B. Harris, S. Satterfield, S. R. Cummings, and M. G. Shlipak Renal function and heart failure risk in older black and white individuals: the health, aging, and body composition study. Arch Intern Med, July 10, 2006; 166(13): 1396 - 1402. [Abstract] [Full Text] [PDF]
|
|
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673
